Ability, Llc - Iii Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6092 Plaza Dr, Tylertown, MS 39667 Phone: 601-441-6161 Fax: 601-444-5036 |
News Archive
Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs." The claims in the issued patent cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate.
Researchers led by Zacharias Mandalenakis from University of Gothenburg in Gothenburg, Sweden, have looked at data from the National registry in Sweden to assess the risk of cancers among children and young adults who have been diagnosed with congenital heart disease compared to those who did not have such a diagnosis.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it will announce the results of its Phase 2a clinical trial for the company's ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes on January 30, 2014.
Researchers at New York University and Tel Aviv University have developed a non-invasive imaging method that can be used to diagnose and monitor a number of diseases, including osteoarthritis and inter-vertebral disc degeneration, in their early stages.
› Verified 2 days ago